vaxigrip tetra suspension for injection / quadrivalent influenza vaccine (split virion, inactivated)
sanofi pasteur 14 espace henry vallée , 69007 lyon, france - influenza vaccine, split virion, inactivated - suspension for injection in pre-filled syringe - influenza vaccine (split virion, inactivated) a/victoria/4897/2022 (h1n1) pdm09 - like strain (a/victoria/4897/2022 ivr-238 15 µg a/thailand/8/2022 (h3n2)-like strain (a/california/122/2022, san-022) 15 µg b/austria/1359417/2021-like strain (b/michigan/01/2021, wild type) 15 µg b/phuket/3073/2013 - like strain (b/phuket/3073/2013, wild type) 15 µg - vaccines
influvac inactivated influenza 0.5 ml vaccine long syringe with 16 mm needle 2017
mylan health pty ltd - influenza virus haemagglutinin -
fluquadri junior inactivated quadrivalent influenza vaccine (split virion), influenza virus haemagglutinin 30mcg, 0.25ml suspens
sanofi-aventis australia pty ltd - influenza virus haemagglutinin -
trivalent influenza vaccine (split virion, inactivated) high dose suspension for injection 0.5ml pre-filled syringes
split virion, inactivated) high dose suspension for injection 0.5ml pre-filled syringes (sanofi pasteur - influenza virus inactivated split (h1n1, h3n2-like, b/brisbane/60/2008-like, strains) - suspension for injection
aflunov(r) prepandemic influenza vaccine, h5n1 (surface antigen, inactivated, adjuvanted) 0.5ml pre-filled syringe
seqirus pty ltd - influenza virus haemagglutinin -
pandemic influenza vaccine h5n1 baxter (whole virion, vero cell derived, inactivated) suspension for injection 0.5 ml dose
au pharma pty ltd - influenza virus haemagglutinin, quantity: 15 microgram/ml - injection, suspension - excipient ingredients: trometamol; water for injections; sodium chloride; polysorbate 80 - pandemic influenza vaccine h5n1 baxter is indicated for prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official recommendations.
pandemic influenza vaccine h5n1 baxter
pharmacy retailing (nz) ltd t/a healthcare logistics - influenza vaccine whole virion, vero cell derived, inactivated 7.5ug (a(h5n1) (a/vietnam/1203/2004)); - suspension for injection - 7.5 mcg/0.5ml - active: influenza vaccine whole virion, vero cell derived, inactivated 7.5ug (a(h5n1) (a/vietnam/1203/2004)) excipient: polysorbate 80 sodium chloride trometamol water for injection - prophylaxis of influenza in an officially declared pandemic situation. the vaccine may only be marketed or distributed in accordance with the directives contained in the current version of the new zealand influenza pandemic action plan.
influvac
abbott medical laboratories ltd, israel - a/cambodia/e0826360/2020 (h3n2)-like strain; a/victoria/2570/2019 (h1n1)pdm09-like strain; b/washington/02/2019 (b/victoria lineage)-like virus - suspension for injection - b/washington/02/2019 (b/victoria lineage)-like virus 15 mcg/dose / 0.5 ml; a/cambodia/e0826360/2020 (h3n2)-like strain 15 mcg / 0.5 ml; a/victoria/2570/2019 (h1n1)pdm09-like strain 15 mcg / 0.5 ml - influenza, inactivated, split virus or surface antigen - influenza, inactivated, whole virus - influenza virus vaccine.
pandemrix
glaxosmithkline biologicals s.a. - split influenza virus inactivated, containing antigen equivalent to a/california/07/2009 (h1n1)-derived strain used nymc x-179a - influenza, human; immunization; disease outbreaks - influenza vaccines - prophylaxis of influenza caused by a (h1n1)v 2009 virus. pandemrix should only be used if the recommended annual seasonal trivalent / quadrivalent influenza vaccines are not available and if immunisation against (h1n1)v is considered necessary (see sections 4.4 and 4.8).pandemrix should be used in accordance with official guidance.
fluvax inactivated influenza vaccine (split virion) thiomersal free 0.5 ml injection syringe 2019
seqirus pty ltd - influenza virus haemagglutinin -